UPDATE 3-MAP Pharma migraine drug hits all goals in study
MAP's drug, Levadex, showed statistical significance at two hours compared to placebo at relieving common symptoms of migraine: pain, nausea, and sensitivity to light and sound.
Levadex, formerly called MAP0004, also reached secondary measures of the 792-patient trial, including pain relief at 30 minutes and sustained relief for 48 hours.
What the community is saying...
Humidity and Precipitation May Trigger Children's Migraines and Headaches
Posted 02/03 Comments (0)
One of the most important parts of Migraine and...
